Targeting neurological abnormalities in lysosomal storage diseases
Raquel van Gool(Boston Children's Hospital), Jaymin Upadhyay(Boston Children's Hospital), Nicholas Todd(Brigham and Women's Hospital), Anthony Tucker-Bartley(Center for Pain and the Brain), Benjamin D. Goodlett(Boston Children's Hospital), Walla Al‐Hertani(Dalhousie University), Frank H. Guenther(Boston University), Olaf A. Bodamer(Broad Institute), Edward Yang(Insper)
Cited by 13
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
A normative spatiotemporal MRI atlas of the fetal brain for automatic segmentation and analysis of early brain growth
|Scientific Reports|2017|373
Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias
|Cell Reports|2017|333
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326